Reditux 500mg Injection
Reditux 500mg Injection Original price was: ₹38,046.00.Current price is: ₹14,000.00.
Back to products
Adbiron 250mg Tablet
Adbiron 250mg Tablet Original price was: ₹42,350.00.Current price is: ₹7,100.00.

Pamorelin LA 22.5mg Injection

Original price was: ₹36,409.00.Current price is: ₹25,500.00.

  Prescription Required

Salt :Triptorelin (22.5mg)

Manufacturer : Dr Reddy’s Laboratories Ltd

Packing : 1 Injection in 1 vial

 

Description

1. Product Introduction

Pamorelin LA 22.5mg Injection is a long-acting hormonal therapy primarily used in the management of hormone-dependent conditions. It contains Triptorelin, a synthetic form of gonadotropin-releasing hormone (GnRH) agonist. Triptorelin works by regulating the levels of certain hormones in the body, particularly the sex hormones like testosterone and estrogen. This action helps to manage various hormone-sensitive conditions, most notably advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty (CPP).

This medication is typically administered by a healthcare professional as an intramuscular injection every 3 months, depending on the condition being treated and patient response. Its long-acting nature allows it to maintain steady hormone suppression over time, ensuring consistent therapeutic effects with fewer doses.

Pamorelin LA is trusted by doctors for its efficiency in managing hormone-responsive diseases and is widely used in both oncology and reproductive health care.


2. Uses of Pamorelin LA 22.5mg Injection

Pamorelin LA 22.5mg Injection is used in the treatment of the following conditions:

  • Advanced Prostate Cancer: It helps to reduce testosterone levels, slowing down the growth and spread of prostate cancer cells.

  • Endometriosis: By reducing estrogen levels, it alleviates symptoms like pelvic pain, menstrual cramps, and infertility associated with endometriosis.

  • Uterine Fibroids: It helps shrink fibroids before surgery or as part of non-surgical management.

  • Central Precocious Puberty (CPP): Used in children to delay early onset puberty by controlling the release of puberty-inducing hormones.

Always consult your healthcare provider before starting this medication, and follow the prescribed dosage strictly.


3. Benefits of Pamorelin LA 22.5mg Injection

Pamorelin LA 22.5mg offers several benefits for individuals suffering from hormone-related health conditions:

  • Effective Hormone Regulation: Triptorelin works at the root level by targeting the pituitary gland, effectively lowering the production of sex hormones.

  • Cancer Management: In prostate cancer, reducing testosterone can significantly slow the progression of cancer and improve quality of life.

  • Non-surgical Management of Conditions: It provides an alternative to surgery in conditions like fibroids and endometriosis by shrinking abnormal tissue growth through hormone suppression.

  • Convenience of Long-Acting Dose: With one injection lasting up to 3 months, it reduces the need for frequent hospital visits or medication administration.

  • Improvement in Symptoms: Patients often report relief from pain, heavy bleeding, and other distressing symptoms caused by hormone-sensitive conditions.

  • Support for Fertility Treatments: In some cases, this medication is also used in fertility protocols to manage hormone levels during assisted reproductive techniques.

These benefits make Pamorelin LA a key component in long-term hormonal therapy protocols.


4. Side Effects of Pamorelin LA 22.5mg Injection

Like all medications, Pamorelin LA may cause side effects in some individuals. Most side effects are manageable and go away with time, but it’s important to be aware of them:

Common Side Effects:

  • Hot flashes

  • Sweating

  • Decreased libido

  • Erectile dysfunction (in men)

  • Irregular or stopped menstruation (in women)

  • Mood swings or depression

  • Injection site pain or swelling

  • Headache

  • Weight gain

Rare But Serious Side Effects:

  • Allergic reactions like rash, itching, or swelling

  • Bone thinning (osteoporosis) with long-term use

  • Increased risk of heart-related problems

  • Sudden onset of symptoms due to initial hormone flare-up (usually transient)

Patients are advised to report any unusual symptoms to their doctor immediately and attend regular follow-ups to monitor their condition and adjust treatment as needed.


5. Frequently Asked Questions (FAQ)

Q1. How does Pamorelin LA 22.5mg Injection work?
A: It works by lowering the levels of sex hormones (testosterone in men and estrogen in women), which helps control the growth of hormone-sensitive tissues or tumors.

Q2. How often do I need to take this injection?
A: Typically, one injection is administered every 12 weeks (3 months), but your doctor will determine the exact frequency based on your condition and response to the treatment.

Q3. Can women use this medication?
A: Yes, it is commonly used in women to treat conditions like endometriosis and uterine fibroids. However, it is not recommended during pregnancy or breastfeeding.

Q4. Can children take Pamorelin LA?
A: Yes, it is prescribed in certain cases like central precocious puberty (CPP) to delay the onset of puberty in children.

Q5. Are the effects of this injection permanent?
A: No, most of its effects are reversible. Once treatment is stopped, hormone levels generally return to normal after some time. However, it should only be stopped under medical supervision.

Q6. Can I experience side effects immediately after injection?
A: Some patients may notice temporary worsening of symptoms due to a short-term increase in hormone levels (flare effect), which usually subsides in a few days.

Q7. Do I need any special tests while using this medicine?
A: Yes, regular blood tests and medical check-ups may be recommended to monitor hormone levels, bone density, and the progress of your condition.

Q8. Is it safe for long-term use?
A: While it can be used long-term under medical supervision, extended use may increase the risk of certain side effects like osteoporosis. Your doctor will weigh the risks and benefits before continuing therapy.


References

  1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1410-11.
  2. Triptorelin pamoate. Slough, Berkshire: Ipsen Ltd.; 2010 [revised 17 Dec. 2016]. [Accessed 23 Jan. 2019] (online) Avaialble from:External Link
  3. Triptorelin pamoate. Martigny, Switzerland: Debio RP; 2000 [Accessed Jul. 2014]. [Accessed 27 Mar. 2019] (online) Available from:External Link
  4. Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:External Link


    Disclaimer

    Online Medicos primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on  Online Medicos Our mission is to support, not replace, the doctor-patient relationship

Reviews (0)
Shipping & Delivery